| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | D |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | A |
| 7. Steady State | B |
| 8. Outlier Analysis | C |
| 9. Normality | B |
| 10. Variance Homogeneity | A |
| 11. ANOVA | B |
| 12. CI | A |
| 13. No of Results | C |
| 14. Concentrations | A |
| 15. Total Score | D4 |
| Comment | Method different from IFCC |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Alanine transaminase (ALT) |
| Unit | U / L |
| Overall Analytical Principle Method | Enzymatic analysis - Not specified |
| Number of Subjects | 11 |
| Number of Subjects included in BV estimation | 11 |
| Ethinicity | Caucasian |
| Age Mean / Median | |
| Age Min | 21.0 |
| Age Max | 27.0 |
| Age SD | |
| Number of Males | 11 |
| Number of Females | |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 1 |
| Study Duration Units | Day |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 3 |
| Interval Units | Day |
| Sampling Times | Start Time:
08:00
End Time: 14:00 |
| Number of Samples | 3 |
| Average Number of Samples Used for BV Estimation | 3.0 |
| Average Number of Replicates | 2.0 |
| Estimates of CVi | 6.7 |
| Calculated Confidence Intervals of CVi | Lower: 4.74, Upper: 9.94 |
| Estimates of CVg | 83.9 |
| Calculated Confidence Intervals of CVg | Lower: 59.36, Upper: 142.57 |
| Analytical CV | 4.2 |
| Calculated Confidence Intervals of Analytical CV | Lower: 3.39, Upper: 5.53 |
| Measurand Mean | 17.3 |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |